Back
CareDx 10K Form
Buy
52
CDNA
CareDx
Last Price:
8.07
Seasonality Move:
20.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDNA News And Ratings
See the #1 stock for the next 7 days that we like better than CDNA
CDNA Financial Statistics
Sales & Book Value
| Annual Sales: | $280.32M |
|---|---|
| Cash Flow: | $-9.98M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.07 |
| Price / Book: | 1.6 |
Profitability
| EPS (TTM): | -3.53000 |
|---|---|
| Net Income (TTM): | $-190.28M |
| Gross Margin: | $178.33M |
| Return on Equity: | -49.77% |
| Return on Assets: | -37.25% |
CareDx Earnings Forecast
Key CareDx Financial Ratios
- The Gross Profit Margin over the past 12 years for CDNA is 63.61%.
- The Selling, General & Administrative Expenses for CDNA have been equal to 71.77% of Gross Profit Margin.
- The Research & Development expenses have been 29.20% of Revenue.
- The Interest Expense is -10.56% of Operating Income.
- The Net Earning history of CDNA is -67.88% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
CareDx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDNA |
| CUSIP: | 14167L |
| Website: | caredx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.02 |
| Quick Ratio: | 3.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |